Inventor
BOUCHARD ANNIE
CA10 patents
Patents
10 patentsUS10258691B2Apr 16, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations84
US10238602B2Mar 26, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC16 citations84
US10349884B2Jul 16, 2019
Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
SIGNPATH PHARMA INC16 citations83
US10449193B2Oct 22, 2019
Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
SIGNPATH PHARMA INC13 citations82
US10532045B2Jan 14, 2020
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
SIGNPATH PHARMA INC6 citations71
US10975111B2Apr 13, 2021
Cardiopathy-reducing phosphodiester lipids
SIGNPATH PHARMA INC3 citations67
US11806401B2Nov 7, 2023
Prevention of drug-induced atrio-ventricular block
SIGNPATH PHARMA INC0 citations61
US11746119B2Sep 5, 2023
Cardiopathy-reducing phosphodiester lipids
SIGNPATH PHARMA INC0 citations56
US11643424B2May 9, 2023
Cardiopathy-reducing phosphodiester lipids
SIGNPATH PHARMA INC0 citations56
US12004868B2Jun 11, 2024
Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
SIGNPATH PHARMA INC0 citations50